Chien Jennifer's Form 4 filing
Rhythm Pharmaceuticals, Inc.RYTM · filed Feb 14, 2025
- Accession no.
- 0001104659-25-014257
- Filed
- Feb 14, 2025
- Trade date
- Feb 12-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $172.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chien JenniferCIK 0001801372 | Officer (EVP, Head of North America) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | SSaleDisposed | −600 | $56.39 | −$33,834 | 4,813 | Direct | |
| Feb 12, 2025 | Common Stock | SSaleDisposed | −10 | $56.41 | −$564.1 | 4,803 | Direct | |
| Feb 12, 2025 | Common Stock | SSaleDisposed | −1,205 | $56.39 | −$67,949.95 | 3,598 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −1,205 | $58.00 | −$69,890 | 2,393 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.